Abstract
Detection of Epstein-Barr virus (EBV) DNA in the cerebrospinal fluid (CSF) is associated with acquired immunodeficiency syndrome (AIDS)-related brain lymphoma. Real-time polymerase chain reaction (PCR) was performed to quantify EBV DNA in CSF and plasma from 42 patients with AIDS-related non-Hodgkin’s lymphoma (NHL). Twenty patients had primary central nervous system lymphoma (PCNSL) and 22 systemic NHL, including 12 with central nervous system involvement (CNS-NHL). As controls, 16 HIV-infected patients with other CNS disorders were examined. EBV DNA was detected in the CSF from 16/20 (80%) patients with PCNSL, 7/22 (32%) with systemic NHL, 8/12 (67%) with CNS-NHL, and 2/16 (13%) of the controls. The viral EBV DNA levels were significantly higher in the CSF from patients with PCNSL or CNS-NHL compared to patients with systemic NHL or controls. EBV DNA was detected in plasma from 5/16 (31%) patients with PCNSL, 9/16 (56%) with systemic NHL, 4/9 (44%) with CNS-NHL, and 4/15 (27%) controls. No difference in plasma viral load was found between patient groups. From the patients with CNS-NHL, plasma samples drawn prior to CNS involvement contained significantly higher EBV DNA levels than those from systemic NHL patients without subsequent CNS involvement. EBV DNA levels in the CSF, but not in plasma, from patients treated with antiherpes drugs were significantly lower than in untreated patients. High CSF EBV DNA levels were found in HIV-associated brain lymphomas and the viral load can be clinically useful. High plasma EBV DNA levels might predict CNS involvement in systemic NHL.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Antinori A, Cingolani A, De Luca A, Gaidano GL, Ammassari A, Larocca LM, Ortona L (1999). Epstein-Barr virus in monitoring the response to therapy of acquired immunodeficiency syndrome-related primary central nervous system lymphoma. Ann Neurol 45: 259–261.
Arribas JR, Clifford DB, Fichtenbaum CJ, Roberts RL, Powderly WG, Storch GA (1995). Detection of Epstein-Barr virus DNA in cerebrospinal fluid for diagnosis of AIDS-related central nervous system lymphoma. J Clin Microbiol 33: 1580–1583.
Cingolani A, Gastaldi R, Fassone L, Piercorti F, Giancola ML, Martini M, De Luca A, Ammassari A, Mazzone C, Pescarmora E, Gaidano GL, Larocca LM, Antinori A (2000). Epstein-Barr infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin’s lymphomas. J Clin Oncol 18: 3325–3330.
Cinque P, Brytting M, Vago L, Castagna A, Paravicini C, Zanchetta N, D’Arminio Monforte A, Wahren B, Lazzarin A, Linde (1993). Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet 342: 398–401.
Cinque P, Vago L, Dahl H, Brytting M, Terreni MR, Fornara C, Racca S, Castagna A, D’Arminio Monforte A, Wahren B, Lazzarin A, Linde A (1996). Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients. AIDS 10: 951–958.
De Luca A, Antinori A, Cingolani A, Larocca LM, Linzalone A, Ammassari A, Scerrati M, Roselli R, Tamburini E, Ortona L (1995). Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma. Br J Haematol 90: 844–849.
Enbom M, Strand A, Falk KI, Linde A (2001). Detection of EBV, but not HHV-8, DNA in cervical secretions from Swedish women by real-time PCR. Sex Transm Dis 28: 300–306.
Ernberg I, Altiok E (1989). The role of Epstein-Barr virus in lymphomas of HIV-carriers. APMIS Suppl 8: 58–61.
Fong IW, Ho J, Lo B, Fong MW (2000). Value of chronic administration of acyclovir and similar agents for protecting against AIDS-related lymphoma: Case control and historical cohort studies. Clin Infect Dis 30: 757–761.
Grulich AE (1999). AIDS-associated non-Hodgkin’s lymphoma in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr Hum Retrovirol 21: S27-S30.
Kenagy DN, Schlesinger Y, Week K, Ritter JN, Gaudreault-Keener MM, Storch GA (1995). Epstein-Barr virus DNA in peripheral blood leukocytes of patients with post-transplant lymphoproliferative disease. Transplant 60: 547.
Kimura H, Morita M, Yabuta Y, Kuzushima K, Kato K, Kojima S, Matsuyama T, Morishima T (1999). Quantitative analysis of Epstein-Barr virus load by using a realtime PCR assay. J Clin Microbiol 37: 132–136.
Laroche C, Drouet EB, Brousset P, Pain C, Boibieux A, Biron F, Icart J, Denoyel GA, Niveleau A (1995). Measurement by polymerase chain reaction of the Epstein-Barr virus load in infectious mononucleosi s and AIDS-related non-Hodgkin’s lymphomas. J Med Virol 46: 66–74.
Levine AM (1992). Acquired immunodeficiency syndrome-related lymphoma. Blood 80: 8–20.
Limaye AP, Huang ML, Atienza EE, Ferrenberg JM, Corey L (1999). Detection of Epstein-Barr virus DNA in sera from transplant recipients with lymphoproliferative disorders. J Clin Microbiol 37: 1113–1116.
Lucas KG, Burton RL, Zimmerman SE, Wang J, Cornetta KG, Robertson KA, Lee CH, Emmanuel DJ (1998). Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation. Blood 91: 3654–3661.
MacMahon EM, Glass JD, Hayward SD, Mann RB, Scott-Becker P, Charache P, McArthur JC, Ambinder RF (1991). Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 338: 969–974.
Niesters HGM, van Esser J, Fries E, Wolthers KC, Cornelissen J, Osterhaus ADME (2000). Development of a real-time quantitative assay for detection of Epstein-Barr virus. J Clin Microbiol 38: 712–715.
Rabkin CS, Marcia AT, Huang J, Von Roenn JH (1999). Kaposi’s sarcoma and non-Hodgkin’s lymphoma incidence trends in AIDS clinical trial group study participants. J Acquir Immune Defic Syndr Hum Retrovirol 21: S31-S33.
Raez L, Cabrai L, Cai JP, Landy H, Sfakianakis G, Byrne GE, Hurley J, Sarpella E, Jahaweera D, Harrington WJ, Jr (1999). Treatment of AIDS-related primary central nervous system lymphoma with zidovudine, ganciclovir and interleukin 2. AIDS Res Hum Retroviruses 15: 713–719.
Rickinson AB, Kieff E (1996). Epstein-Barr virus. In: Fields virology, Fields BN (ed.). Philadelphia, PA: Lippincott-Raven, pp. 2397–2446.
Schmidt W, Anagnostopoulos I, Scherubl H (2000). Virostatic therapy for advanced lymphoproliferation associated with the Epstein-Barr virus in an HIV-infected patients (letter). N Engl J Med 342: 440–441.
Shibata D, Weiss LM, Hernandez AM, Nathwani BN, Bernstein L, Levine AM (1993). Epstein-Barr virus-associated non-Hodgkin’s lymphoma in patients infected with the human immunodeficiency virus. Blood 81: 2102–2109.
Stevens SJC, Vervoot MBHJ, van den Brule AJC, Meenhorst PL, Meijer JLM, Middelhorp JM (1999). Monitoring of Epstein-Barr virus DNA load in peripheral blood by quantitative competitive PCR. J Clin Microbiol 37: 2852–2857.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bossolasco, S., Cinque, P., Ponzoni, M. et al. Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma. Journal of NeuroVirology 8, 432–438 (2002). https://doi.org/10.1080/13550280260422730
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1080/13550280260422730